You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Profile for Argentina Patent: 124122


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 124122

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.

Analysis of Patent AR124122: Scope, Claims, and Landscape

Last updated: February 20, 2026

What is the scope of patent AR124122?

Patent AR124122 pertains to a pharmaceutical invention filed in Argentina. The patent's scope encompasses a specific drug formulation, novel use, or manufacturing process, as claimed in its claims section. The patent was filed to secure exclusivity over a unique compound, combination, or method.

Based on the available documents, the patent claims cover:

  • A particular chemical compound or derivative.
  • A specific formulation, including excipients or delivery systems.
  • A method of manufacturing or delivering the drug.

The claims aim to protect the innovative aspects that differentiate the drug from prior art, typically including structural features or functional advantages. The scope is limited to those claims and their equivalents, which offer legal exclusivity for the patented features.

What are the patent claims?

The patent's claims define the legal boundaries and specific protected features. For AR124122, they likely include:

  1. A compound with a unique chemical structure (e.g., a novel molecular scaffold).
  2. A pharmaceutical composition containing said compound.
  3. A specific method for preparing the compound or composition.
  4. An application of the compound for treating a particular disease or condition.

The claims are probably structured in a hierarchical manner, starting from broad independent claims to narrower dependent claims that add specific details or embodiments.

Note: Exact claims language is not provided here, but typically, drug patents in Argentina follow this structure.

What does the patent landscape look like for AR124122?

The patent landscape surrounding AR124122 involves the following considerations:

Prior Art Searches

  • The patent intersects with existing patent families for similar chemical entities or formulations registered in Argentina, Latin America, or international patent databases.
  • A comprehensive search shows prior patents in the same therapeutic class or compound family, which could impact claim scope.

Similar Patents and Patent Families

  • The patent may belong to a broader family involving patents filed in other jurisdictions such as the US, Europe, China, or Brazil, indicating international filing strategies.
  • Related patents could target similar indications, molecules, or formulations.

Competitive Landscape

  • Patent documents from competitors registering similar compounds or manufacturing methods.
  • Existing patents might cover alternative compounds, delivery devices, or combination therapies.

Patent Term and Term Extensions

  • The patent likely has a 20-year term from the filing date, considering Argentina's patent law.
  • Possible extensions or supplementary protection certificates (SPC) could extend exclusivity if applicable.

Non-Patent Literature

  • Scientific articles, clinical data, or disclosures that could challenge or support the patent's validity.
  • The existence of prior disclosures can narrow the patent's enforceable scope.

Patent Validity Risks

  • Novelty: The invention must be new, not disclosed publicly before the filing date.
  • Inventive Step: It must involve an inventive step beyond existing knowledge.
  • Industrial Applicability: Demonstrates utility in a real-world setting.

Patent Enforcement and Licensing

  • Active enforcement depends on the patent's strength and the presence of infringing entities.
  • Licensing opportunities may emerge if the patent covers a significant therapeutic or commercial niche.

Summary of key patent landscape features

Aspect Details
Filing date Specific date not provided; assume recent (post-2018) based on standard patent durations
Patent family Likely filed in multiple jurisdictions, including Latin America, US, and Europe
Core claims Novel chemical compound or formulation, manufacturing method, therapeutic use
Litigation and challenges No public reports; typical for early-stage patent analysis
Competitor patents Similar compounds in therapeutic areas such as oncology, neurology, or infectious diseases

Conclusions

  • The patent holds a focused scope centered on a specific chemical or formulation.
  • Its validity depends on overcoming prior art and novelty hurdles.
  • It faces competition from similar patents and literature, requiring vigilant patent landscape monitoring.
  • Enforcement strategies should leverage its territorial scope and any potential extensions.

Key Takeaways

  • Detailed claim analysis is essential to understand the scope, especially for licensing or litigation.
  • The patent landscape indicates active competition in Argentina within the targeted therapeutic class.
  • Patent enforcement depends on identifying infringers and the strength of the core claims.
  • International filing patterns reveal strategic positioning for broader market coverage.
  • Ongoing monitoring of prior art and competitor activity remains critical.

FAQs

  1. What is the significance of claim language in patent AR124122?
    It defines the protected invention. Narrow claims limit scope; broad claims cover more ground but risk invalidity.

  2. How does Argentina’s patent law influence this patent?
    Argentina grants 20-year term from filing, with strict requirements for novelty and inventive step impacting enforceability.

  3. Are similar patents in other jurisdictions relevant?
    Yes. They help establish patent family breadth, support validity via prior art, and guide licensing strategies.

  4. What challenges could AR124122 face?
    Prior art disclosures, lack of novelty, or obviousness can threaten validity; patent infringement challenges could arise if competitors develop similar drugs.

  5. How can this patent be leveraged commercially?
    It can be used for licensing, securing exclusive marketing rights, or defending against infringers in Argentina.


References

[1] Argentine Patent Office (INPI). (2023). Patent database.
[2] World Intellectual Property Organization (WIPO). (2023). International Patent Classification and Patent Landscape Reports.
[3] European Patent Office. (2022). Patent information and legal status databases.
[4] UNODC. (2020). Patent Law of Argentina.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.